Arie Mayer Net Worth & Insider Trades
Arie Mayer - Director, Oramed Pharmaceuticals Inc
What is Arie Mayer's Net Worth?
The current estimated net worth of Oramed Pharmaceuticals Inc's Director, Arie Mayer, is estimated to be about $96.6K . Arie Mayer owns about 26,809 units of Oramed Pharmaceuticals Inc common stock. In the last 3 years at Oramed Pharmaceuticals Inc, Arie Mayer has sold an estimated value of $76.8K worth.
What is Arie Mayer's Past Insider Trading?
Arie Mayer's largest purchase order was 8,809 units , worth over $19.52K on April 4, 2023. Arie Mayer's largest sale order was 3,000 units , worth over $76.8K on May 10, 2022. In total, Arie Mayer has made about 6 transactions over 3 years of their time at Oramed Pharmaceuticals Inc. Arie Mayer usually trades in January and April, with the busiest year in 2022.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Arie Mayer
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Arie Mayer's' Mailing Address?
- Mailing address is Moran 16 Kfar Saba L3 4428890 Israel
Oramed Pharmaceuticals Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Nadav Kidron | 2020 | $439,076 | $220,582 | $569,062 | $539,131 | $1,767,851 |
| Nadav Kidron | 2019 | $419,460 | $224,975 | $398,910 | $507,750 | $1,551,095 |
| Nadav Kidron | 2018 | $436,310 | $148,795 | $522,569 | $442,326 | $1,550,000 |
| Miriam Kidron | 2020 | $305,840 | $70,000 | $299,506 | $13,354 | $688,700 |
| Miriam Kidron | 2019 | $267,386 | $123,149 | $211,128 | $14,503 | $616,166 |
| Miriam Kidron | 2018 | $273,595 | $46,614 | $253,204 | $13,643 | $587,056 |
| Avraham Gabay | 2020 | $130,554 | $15,591 | - | $44,912 | $191,418 |
| Avraham Gabay | 2019 | $32,122 | - | $73,928 | $9,441 | $115,491 |
| Joshua Hexter | 2020 | $190,801 | $12,169 | $351,128 | $54,735 | $608,833 |
| Joshua Hexter | 2019 | $52,848 | - | - | $9,022 | $61,870 |
| Joshua Hexter | 2018 | $161,002 | $26,895 | $269,196 | $50,505 | $507,598 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/1176309/000121390021039099/ea144766-def14a_oramedpharma.htm
What are Oramed Pharmaceuticals Inc's Past Insider Trades?
Oramed Pharmaceuticals Inc's most recent insider trade came on April 4, 2023 by Arie Mayer who bought 8,809 units worth $19.52K . In the last 15 years, insiders at Oramed Pharmaceuticals Inc have sold an estimated value of $12.78M and bought an estimated value of $6.61M worth of shares. Insider trading is most common in February and April, with the busiest year in 2022. The most active traders at the company are Nadav Kidron, President and CEO, Miriam Kidron, Chief Scientific Officer, and Leonard Sank, Director .
ORAMED PHARMACEUTICALS INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||